These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 8090664)

  • 1. [Results of treating uremia anemia with human recombinant erythropoietin].
    Litwin M; Grenda R; Jelonek A
    Pol Tyg Lek; 1994 Feb 7-14; 49(6-7):132-4. PubMed ID: 8090664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Human recombinant erythropoietin in treatment of uremic anemia in children with continual ambulatory peritoneal dialysis].
    Litwin M; Boguszewska-Baczkowska A; Jelonek A
    Pol Tyg Lek; 1994 Feb 7-14; 49(6-7):135-6. PubMed ID: 8090665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Use of erythropoietin in children with terminal renal insufficiency treated with chronic hemodialysis].
    Peco-Antić A; Popović-Rolović M; Jovanović O; Kostić M; Kruscić D
    Srp Arh Celok Lek; 1992; 120(5-6):147-52. PubMed ID: 1465668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of anemia in patients on a regular dialysis program using human recombinant erythropoietin].
    Sulková S; Kvasnicka J; Kasl M; Kozlová J; Podrouzek P; Bartůnková J; Válek A
    Cas Lek Cesk; 1989 Sep; 128(40):1257-60. PubMed ID: 2582471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Personal experience with the use of human recombinant erythropoietin in the treatment of anemia in children with chronic renal insufficiency].
    Podracká L; Sasinka M; Roland R; Böör A
    Cesk Pediatr; 1992 May; 47(5):268-71. PubMed ID: 1638649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Importance of iron status monitoring during erythropoietin treatment in uremic predialysis patients.
    Rutkowski B; Debska-Slizień A; Biedunkiewicz B; Bułło B
    Ann Univ Mariae Curie Sklodowska Med; 1994; 48 Suppl 3():17-21. PubMed ID: 8192528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of renal anemia.
    Peco-Antic A
    Turk J Pediatr; 2005; 47 Suppl():19-27. PubMed ID: 15884663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correction of anaemia in haemodialysis patients with recombinant human erythropoietin.
    Boran M; Dalva I; Yazicioğlu A; Akbay E; Cetin S
    Int Urol Nephrol; 1993; 25(2):197-203. PubMed ID: 8365853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evoked potentials before and after anemia correction with recombinant human erythropoietin in end-stage renal disease.
    Suppiej A; Montini G; Casara G; Polo A; Zacchello G; Zacchello F
    Child Nephrol Urol; 1992; 12(4):197-201. PubMed ID: 1473092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical effects of recombinant human erythropoietin for the treatment of anemia in end stage renal disease patients on dialysis.
    Uthayanaka Y; Jirajan B; Krairithichai U; Jantavanich N
    Southeast Asian J Trop Med Public Health; 1993 Sep; 24(3):577-82. PubMed ID: 8160072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant human erythropoietin treatment: investigational new drug protocol for the anemia of the acquired immunodeficiency syndrome. Overall results.
    Phair JP; Abels RI; McNeill MV; Sullivan DJ
    Arch Intern Med; 1993 Dec; 153(23):2669-75. PubMed ID: 8250662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant human erythropoietin in renal transplant recipients with renal anemia.
    Traindl O; Barnas U; Franz M; Falger S; Klauser R; Kovarik J; Graf H
    Clin Transplant; 1994 Feb; 8(1):45-8. PubMed ID: 8136567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Orally administrated Juzen-taiho-to/TJ-48 ameliorates erythropoietin (rHuEPO)-resistant anemia in patients on hemodialysis.
    Nakamoto H; Mimura T; Honda N
    Hemodial Int; 2008 Oct; 12 Suppl 2():S9-S14. PubMed ID: 18837771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of i.v. iron alone or in combination with low-dose erythropoietin in the rapid correction of anemia of chronic renal failure in the predialysis period.
    Silverberg DS; Blum M; Agbaria Z; Deutsch V; Irony M; Schwartz D; Baruch R; Yachnin T; Steinbruch S; Iaina A
    Clin Nephrol; 2001 Mar; 55(3):212-9. PubMed ID: 11316241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Single weekly dose of recombinant erythropoietin in children with chronic renal insufficiency].
    Guízar JM; Gutiérrez MJ; Sánchez G; Kornhauser C
    Rev Invest Clin; 1996; 48(3):173-7. PubMed ID: 8966377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does anemia correction by rHuEPO improve uremic cardiopathy?
    Carletti P; Bibiano L; Boggi R; Taruscia D; Mioli V
    Kidney Int Suppl; 1993 Jun; 41():S70-1. PubMed ID: 8320949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of anemia in patients with chronic renal insufficiency with recombinant human erythropoietin].
    Djukanović Lj; Lezaić V
    Srp Arh Celok Lek; 1996; 124(3-4):93-7. PubMed ID: 9102827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Does aluminum affect the effectiveness of human recombinant erythropoietin in the treatment of anemia in dialyzed patients?].
    Sulková S; Laurincová Z; Kvasnicka J
    Cas Lek Cesk; 1990 Jan; 129(4):113-5. PubMed ID: 2331725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant human erythropoietin resistance in hemodialysis. Effects of paired filtration dialysis.
    Carozzi S; Nasini MG; Santoni O; Tirotta A; Sanna A
    ASAIO J; 1997; 43(5):M535-8. PubMed ID: 9360100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical and economic significance of iron replacement in anemia treated with recombinant human erythropoietin in patients on hemodialysis].
    Vanková S; Safárová R; Horácková M; Herink J; Rychlík I; Bahbouh R; Půtová I
    Cas Lek Cesk; 2001 Apr; 140(7):209-13. PubMed ID: 11374225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.